Form 4 for DNA Ginkgo Bioworks Holdings, Inc.
Accepted 2023-01-31 00:00:00 ET · period of report 2023-01-27 · accession 0001127602-23-002757 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-01-31 | 2023-01-27+ | DNA | Kelly Jason R | See remarks, Dir | S - Sale | $1.86 | -301.9K | 14.39M | -2% | -$560.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-01-27 | S | D | 145,907 | $1.82 | 14,549,962 | D | — | — | |
| 2 | Common | Class A Common Stock | 2023-01-30 | S | D | 156,012 | $1.89 | 14,393,950 | D | — | — |